Research programme: viral infections therapeutics - Achillion/Entomed
Alternative Names: Antivirals - Achillion/EntomedLatest Information Update: 05 Feb 2020
At a glance
- Originator Achillion Pharmaceuticals; Entomed
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 28 Jan 2020 Achillion Pharmaceuticals has been acquired by Alexion Pharmaceuticals
- 21 Mar 2007 Discontinued - Preclinical for Viral infections in France (unspecified route)
- 21 Mar 2007 Discontinued - Preclinical for Viral infections in USA (unspecified route)